Status of lymph node staging

Scandinavian Journal of Surgery

Volumn 91, Issue 3, 2002, Pages 263-267

  Nieweg, Omgo E ^a   Estourgie, S H ^a   Deurloo, E E ^a   Rutgers, E J Th ^a   Kroon, B B R ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Axillary lymph nodes; Breast neoplasms; Neoplasm staging; Review; Sentinel lymph node biopsy

Indexed keywords

AXILLARY LYMPH NODE; CANCER STAGING; DIAGNOSTIC ACCURACY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MINIMALLY INVASIVE SURGERY; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE BIOPSY;

EID: 0036412626     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690209100309     Document Type: Review

References (33)

1. NIH consensus conference: Treatment of early-stage breast cancer. JAMA 1991;265:664-667
2. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P: Axillary lymph node dissection for T1a breast cancer. Cancer 1994;73:664-667
3. Cady B: The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer 1994;73:505-508
4. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging is limited. Limited axillary dissection as a determinate of histologic nodal status in carcinoma of the breast is enough. Survival not better with complete axillary node dissection. Surg Gynecol Obstet 1981;152:765-772
5. Cutler SJ, Axtell LM, Schottenfeld D, Farrow JH: Clinical assessment of lymph nodes in carcinoma of the breast. Surg Gynecol Obstet 1970;131:41-52
6. Isaacs RJ, Ford JM, Allan SG, Forgeson GV, Gallagher S: Role of computed tomography in the staging of primary breast cancer. Br J Surg 1993;80:1137
7. Wahl RL, Cody RL, Hutchins GD, Mudgett EE: Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology 1991;179:765-770
8. Nieweg OE, Kim EE, Wong W, Broussard WF, Singletary SE, Hortobagyi GN, Tilbury RS: Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993;71:3920-3925
9. Morton DL, Wen D, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;27:392-399
10. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rappaport D, Seigler HF, Balch CM: The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-767
11. Kapteijn BAE, Nieweg OE, Peterse JL, Rutgers EJT, Hart AAM, Dongen van JA, Kroon BBR: Identification and biopsy of the sentinel node in breast cancer. Eur J Surg Oncol 1998;24:427-430
12. Nieweg OE, Jansen L, Valdés Olmos RA, Rutgers EJT, Peterse JL, Hoefnagel CA, Kroon BBR: Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999;26:S11-16
13. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, Glass EC, Turner RR: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-2559
14. Veronesi U, Galimberti V, Zurrida S, Pigatto F, Veronesi P, Robertson C, Paganelli G, Sciascia V, Viale G: Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001;37:454-458
15. Roumen RM, Kuijt GP, Liem IH, van Beek MW: Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001;88:1639-1643
16. Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Waynad W: Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001;77:165-170
17. Torrenga H, Meijer S, Van der Sijp JRM: Recurrence after long terrm follow-up (> 40 month) in 100 SN negative breast cancer patients (Abstract). Eur J Surg Oncol 2002,28:304
18. Tanis PJ, Boom RPA, Schraffordt Koops H, Faneyte I, Peterse JL, Nieweg OE, Rutgers EJT, Kroon BBR: Intraoperative examination of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001;8:221-216
19. Estourgie SH, Tanis PJ, Nieweg OE, Valdés Olmos RA, Rutgers EJT, Peterse JL, Kroon BBR: Evaluation of false negative sentinel node biopsies in breast cancer (Abstract). Eur J Surg Oncol 2002;28:306
20. Nieweg OE, Tanis PJ, de Vries JD, Kroon BB: Sensitivity of sentinel node biopsy in melanoma. J Surg Oncol 2001;78:223-224
21. Jacobs IA, Chevinsky AH, Swayne LC, Magidson JG, Britto EJ, Smith TJ: Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up. J Surg Oncol 2001;77:157-164
22. Nieweg OE, Tanis PJ, Kroon BBR: The definition of a sentinel node. Ann Surg Oncol 2001;8:538-541
23. Tanis PJ, Nieweg OE, Hart AAM, Kroon BBR: The illusion of the leaning phase in lymphatic mapping. Ann Surg Oncol 2002;9:142-147
24. Schijven M, Rutten H, Roumen R: Implementation of the sentinel node biopsy: A survey among surgeons in the Netherlands. Eur J Surg Oncol 2000;26:431-432
25. Zervos EE, Saha S, Hoshaw-Woodard S, Wheatley GH, Burak WE: Localizing the sentinel node outside of the specialty center: Success of a lymphatic mapping course in disseminating new technology. Ann Surg Oncol 2001;8:7-12
26. Cody HS, III, Urban JA: Internal mammary node status: A major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 1995;2:32-37
27. Jansen L, Doting MHE, Rutgers EJT, de Vries J, Valdés Olmos RA, Nieweg OE: Clinical relevance of sentinel nodes outside the axilla in patients with breast cancer. Br J Surg 2000;87:920-925
28. van der Ent FW, Kengen RA, van der Pol HA, Povel JA, Stroeken HJ, Hoofwijk AG: Halsted revisited: Internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001;234:79-84
29. Dupont EL, Salud CJ, Peltz ES, Nguyen K, Whitehead GF, Ku NN, Reintgen DS, Cox CE: Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg 2001;182:321-324
30. Tanis PJ, Nieweg OE, Valdés Olmos RA, Peterse JL, Rutgers EJT, Hoefnagel CA, Kroon BBR: Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer 2002;87:705-710
31. Berns A: Gene expression in diagnosis. Nature 2000;403:491-492
32. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536
33. Nieweg OE. A response to Lee M: Ellis's editorial: A perspective on sentinel lymph node biopsy in colorectal cancer: The race between surgical technology and molecular oncology. Ann Surg Oncol 2001;8:271